Yasser Perera

1.2k total citations
50 papers, 677 citations indexed

About

Yasser Perera is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Yasser Perera has authored 50 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 9 papers in Infectious Diseases and 7 papers in Oncology. Recurrent topics in Yasser Perera's work include SARS-CoV-2 and COVID-19 Research (9 papers), Ubiquitin and proteasome pathways (5 papers) and Mass Spectrometry Techniques and Applications (4 papers). Yasser Perera is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), Ubiquitin and proteasome pathways (5 papers) and Mass Spectrometry Techniques and Applications (4 papers). Yasser Perera collaborates with scholars based in Cuba, Argentina and China. Yasser Perera's co-authors include Silvio E. Perea, Hernán G. Fariña, Boris Acevedo, Daniel F. Alonso, Marta Ayala, Jorge Gavilondo, Roberto Gómez, Gertrudis Rojas, Yadira Lobaina and Daniel E. Gómez and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yasser Perera

47 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasser Perera Cuba 16 513 129 85 58 58 50 677
Claudio Zamperini Italy 23 446 0.9× 90 0.7× 62 0.7× 49 0.8× 47 0.8× 39 1.0k
Martin Schlapschy Germany 17 651 1.3× 178 1.4× 225 2.6× 36 0.6× 77 1.3× 31 1.0k
Kohei Tsuji Japan 16 443 0.9× 207 1.6× 124 1.5× 38 0.7× 44 0.8× 57 776
Rajesh Vij United States 10 365 0.7× 265 2.1× 104 1.2× 51 0.9× 36 0.6× 13 726
Patricia Walden Australia 11 280 0.5× 156 1.2× 52 0.6× 29 0.5× 41 0.7× 20 534
Ronny Schmidt Germany 12 715 1.4× 195 1.5× 132 1.6× 40 0.7× 30 0.5× 24 1.0k
Timothy M. Jacobs United States 13 505 1.0× 92 0.7× 99 1.2× 27 0.5× 112 1.9× 28 812
Boris Acevedo Cuba 16 446 0.9× 80 0.6× 79 0.9× 28 0.5× 64 1.1× 25 682
Jinzi J. Wu United States 16 777 1.5× 175 1.4× 60 0.7× 23 0.4× 96 1.7× 41 1.2k
Xiamei Zhang United States 12 433 0.8× 155 1.2× 102 1.2× 32 0.6× 20 0.3× 21 789

Countries citing papers authored by Yasser Perera

Since Specialization
Citations

This map shows the geographic impact of Yasser Perera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasser Perera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasser Perera more than expected).

Fields of papers citing papers by Yasser Perera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasser Perera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasser Perera. The network helps show where Yasser Perera may publish in the future.

Co-authorship network of co-authors of Yasser Perera

This figure shows the co-authorship network connecting the top 25 collaborators of Yasser Perera. A scholar is included among the top collaborators of Yasser Perera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasser Perera. Yasser Perera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lobaina, Yadira, Rong Chen, Edith Suzarte Portal, et al.. (2024). A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS-CoV-2, to Induce a Broader Response. Vaccines. 12(6). 588–588. 4 indexed citations
2.
Lobaina, Yadira, Rong Chen, Edith Suzarte Portal, et al.. (2023). Cross-Reactive Profile Against Two Conserved Coronavirus Antigens in Sera from SARS-CoV-2 Hybrid and Vaccinated Immune Donors. Viral Immunology. 36(3). 222–228. 3 indexed citations
3.
Lobaina, Yadira, Rong Chen, Edith Suzarte Portal, et al.. (2023). Broad humoral immunity generated in mice by a formulation composed of two antigens from the Delta variant of SARS-CoV-2. Archives of Virology. 168(7). 190–190. 1 indexed citations
4.
Perez, George, Vladimir Besada, Luis Javier González, et al.. (2022). CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model. Biomedicines. 11(1). 43–43. 5 indexed citations
5.
Perez, George, Yassel Ramos, Viviana Falcón, et al.. (2022). Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection. Viruses. 14(3). 552–552. 9 indexed citations
6.
7.
Besada, Vladimir, George Perez, Yassel Ramos, et al.. (2021). Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945. Cells. 10(2). 338–338. 8 indexed citations
8.
Perez, George, Vladimir Besada, Yassel Ramos, et al.. (2021). Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300. Biomedicines. 9(7). 766–766. 13 indexed citations
9.
Lobaina, Yadira, et al.. (2021). Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination. International Journal of Peptide Research and Therapeutics. 27(4). 2873–2882. 4 indexed citations
10.
Garay, Hilda, Luis Ariel Espinosa, Yasser Perera, et al.. (2018). Characterization of low‐abundance species in the active pharmaceutical ingredient of CIGB‐300: A clinical‐grade anticancer synthetic peptide. Journal of Peptide Science. 24(6). e3081–e3081. 12 indexed citations
11.
Perea, Silvio E., Idania Baladrón, Carmen Valenzuela, & Yasser Perera. (2018). CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation. Seminars in Oncology. 45(1-2). 58–67. 40 indexed citations
12.
Perera, Yasser, et al.. (2015). Predicting CK2 beta-dependent substrates using linear patterns. Biochemistry and Biophysics Reports. 4. 20–27. 9 indexed citations
13.
Perera, Yasser, Seidy Pedroso‐Santana, Orlando Borrás‐Hidalgo, et al.. (2015). Pharmacologic inhibition of the CK2-mediated phosphorylation of B23/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis. Molecular and Cellular Biochemistry. 404(1-2). 103–112. 8 indexed citations
14.
Perera, Yasser, et al.. (2014). Implementation of a competitive ELISA for pharmacokinetics studies of CIGB-300 in human plasma. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Perera, Yasser, et al.. (2014). Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models. Molecular and Clinical Oncology. 2(6). 935–944. 23 indexed citations
16.
Yero, Daniel, et al.. (2012). Predicted proteins of Neisseria meningitidis as potential vaccine candidates: from in silico analyses to experimental corroboration. SHILAP Revista de lepidopterología. 29(1). 22–28. 2 indexed citations
17.
Fariña, Hernán G., Yasser Perera, Silvio E. Perea, et al.. (2011). CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo. Experimental Cell Research. 317(12). 1677–1688. 19 indexed citations
18.
Perera, Yasser, Hernán G. Fariña, Jeovanis Gil, et al.. (2009). Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity. Molecular Cancer Therapeutics. 8(5). 1189–1196. 47 indexed citations
19.
Yero, Daniel, Yanet Climent, Lázaro Betancourt, et al.. (2009). Analysis of the genetic variability and immunological properties of the NlpB antigen, a novel protein identified in Neisseria meningitidis. SHILAP Revista de lepidopterología. 26(1). 84–87.
20.
Acevedo, Boris, et al.. (2006). Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma. The Prostate. 66(10). 1029–1036. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Zamperini Breakdown of academic impact, for papers by Martin Schlapschy Breakdown of academic impact, for papers by Kohei Tsuji Breakdown of academic impact, for papers by Rajesh Vij Breakdown of academic impact, for papers by Patricia Walden Breakdown of academic impact, for papers by Ronny Schmidt Breakdown of academic impact, for papers by Timothy M. Jacobs Breakdown of academic impact, for papers by Boris Acevedo Breakdown of academic impact, for papers by Jinzi J. Wu Breakdown of academic impact, for papers by Xiamei Zhang
Rankless by CCL
2026